Applying radiobiological principles to combined modality treatment of head and neck cancer - The time factor

被引:101
作者
Peters, LJ [1 ]
Withers, HR [1 ]
机构
[1] UNIV CALIF LOS ANGELES,DEPT RADIAT ONCOL,LOS ANGELES,CA 90024
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 39卷 / 04期
关键词
head and neck cancer; time factor; tumor cell regeneration; combined modality treatment; protocol optimization;
D O I
10.1016/S0360-3016(97)00466-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Combined modality treatment is indicated for most advanced stage head and neck cancers, It is postulated that the efficacy of combined modality regimens could be enhanced by applying principles derived from radiotherapy fractionation studies to optimize the time factor in treatment scheduling. Methods and Materials: The premise that tumor clonogens surviving a therapeutic intervention undergo accelerated repopulation in a time-dependent fashion as their numbers are depleted is used as a model to interpret the results of various chemoradiotherapy and postsurgical radiotherapy protocols and to suggest ways in which future combined modality regimens can be more rationally designed. Results: Meta-analyses of chemoradiotherapy trials show the general superiority of concomitant vs. neoadjuvant sequential protocols, There is also emerging evidence that both the duration of postoperative radiotherapy and the delay in its instigation affect treatment outcome, These results are compatible with the hypothesis that the overall duration of the ''package deal'' of combined modality treatment is an important determinant of outcome, However, a large decrease in duration of the ''package deal'' does not necessarily translate into a therapeutic gain because the total dose has to be lowered to prevent intolerable acute reactions, In these circumstances tumor control will improve only if the reduced treatment time circumvents more tumor cell regeneration than the cytoreduction that could be achieved by the extra dose tolerable in a longer time period, More modest reductions in treatment time can be accomplished without dose reduction and so avoid this risk, The design of new protocols should take account of the fact that regeneration of tumor clonogens can be predicted to be nonuniform with time, Thus, the greatest therapeutic gain should be achieved by targeting periods of maximal regenerative capacity for shortening or, alternatively, for intensification of treatment, These periods are the latter part of a course of radiotherapy or chemotherapy and the early postoperative phase after surgery. Conclusions: The rational design of combined modality protocols should include principles concerning the time factor derived from radiotherapy fractionation studies, Periods of maximal tumor cell regeneration should be targeted for shortening or for treatment intensification, Any dose sacrifice necessitated by reducing treatment duration must be less than the dose equivalent of regeneration during the same time period. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:831 / 836
页数:6
相关论文
共 31 条
[21]   PROSPECTIVE RANDOMIZED TRIAL COMPARING HYPERFRACTIONATED VERSUS CONVENTIONAL RADIOTHERAPY IN STAGES-III AND STAGES-IV OROPHARYNGEAL CARCINOMA [J].
PINTO, LHJ ;
CANARY, PCV ;
ARAUJO, CMM ;
BACELAR, SC ;
SOUHAMI, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (03) :557-562
[22]   SINGLE FRACTION PER DAY VERSUS 2 FRACTIONS PER DAY VERSUS RADIOCHEMOTHERAPY IN THE TREATMENT OF HEAD AND NECK-CANCER [J].
SANCHIZ, F ;
MILLA, A ;
TORNER, J ;
BONET, F ;
ARTOLA, N ;
CARRENO, L ;
MOYA, LM ;
RIERA, D ;
RIPOL, S ;
CIRERA, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (06) :1347-1350
[23]   Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: An interim report [J].
Saunders, MI ;
Dische, S ;
Barrett, A ;
Parmar, MKB ;
Harvey, A ;
Gibson, D .
BRITISH JOURNAL OF CANCER, 1996, 73 (12) :1455-1462
[24]   COMBINED MODALITY TREATMENT WITH RADIOTHERAPY AND CHEMOTHERAPY [J].
TANNOCK, IF .
RADIOTHERAPY AND ONCOLOGY, 1989, 16 (02) :83-101
[25]   A PROSPECTIVE TRIAL OF ACCELERATED RADIOTHERAPY IN THE POSTOPERATIVE TREATMENT OF HIGH-RISK SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
TROTTI, A ;
KLOTCH, D ;
ENDICOTT, J ;
RIDLEY, M ;
GREENBERG, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01) :13-21
[26]   POSTOPERATIVE IRRADIATION IMPAIRS OR ENHANCES WOUND STRENGTH DEPENDING ON TIME OF ADMINISTRATION [J].
VEGESNA, V ;
MCBRIDE, WH ;
WITHERS, HR .
RADIATION RESEARCH, 1995, 143 (02) :224-228
[27]   FAILURE IN THE NECK FOLLOWING MULTIMODALITY TREATMENT FOR ADVANCED HEAD AND NECK-CANCER [J].
VIKRAM, B ;
STRONG, EW ;
SHAH, JP ;
SPIRO, R .
HEAD & NECK SURGERY, 1984, 6 (03) :724-729
[28]   LATE NORMAL TISSUE SEQUELAE FROM RADIATION-THERAPY FOR CARCINOMA OF THE TONSIL - PATTERNS OF FRACTIONATION STUDY OF RADIOBIOLOGY [J].
WITHERS, HR ;
PETERS, LJ ;
TAYLOR, JMG ;
OWEN, JB ;
MORRISON, WH ;
SCHULTHEISS, TE ;
KEANE, T ;
OSULLIVAN, B ;
VANDYK, J ;
GUPTA, N ;
WANG, CC ;
JONES, CU ;
DOPPKE, KP ;
MYINT, S ;
THOMPSON, M ;
PARSONS, JT ;
MENDENHALL, WM ;
DISCHE, S ;
AIRD, EGA ;
HENK, M ;
BIDMEAD, MAM ;
SVOBODA, V ;
CHON, Y ;
HANLON, AL ;
PETERS, TL ;
HANKS, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (03) :563-568
[29]   LOCAL-CONTROL OF CARCINOMA OF THE TONSIL BY RADIATION-THERAPY - AN ANALYSIS OF PATTERNS OF FRACTIONATION IN 9 INSTITUTIONS [J].
WITHERS, HR ;
PETERS, LJ ;
TAYLOR, JMG ;
OWEN, JB ;
MORRISON, WH ;
SCHULTHEISS, TE ;
KEANE, T ;
OSULLIVAN, B ;
VANDYK, J ;
GUPTA, N ;
WANG, CC ;
JONES, CU ;
DOPPKE, KP ;
MYINT, S ;
THOMPSON, M ;
PARSONS, JT ;
MENDENHALL, WM ;
DISCHE, S ;
AIRD, EGA ;
HENK, JM ;
BIDMEAD, MAM ;
SVOBODA, V ;
CHON, Y ;
HANLON, AL ;
PETERS, TL ;
HANKS, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (03) :549-562
[30]   THE HAZARD OF ACCELERATED TUMOR CLONOGEN REPOPULATION DURING RADIOTHERAPY [J].
WITHERS, HR ;
TAYLOR, JMG ;
MACIEJEWSKI, B .
ACTA ONCOLOGICA, 1988, 27 (02) :131-146